Shirkhan Amikishiyev
5PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 14, 2025
Potential Predictors of the Outcome of Tocilizumab Treatment in Patients with COVID-19-Associated Hyperinflammation.Shirkhan Amikishiyev, Murat Bektaş, Mehmet Güven Günver
|Oct 17, 2024
Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study.Shirkhan Amikishiyev, Yasemin Yalçınkaya, Konul Mammadova
|May 30, 2024
Efficacy of rituximab on disease activity, severity, and disease-related damage in patients with immunosuppressive-resistant systemic sclerosis.Yasemin Yalçinkaya, Bahar Artim Esen, Shirkhan Amikishiyev
|Dec 12, 2022
Criteria for Hyperinflammation Developing in COVID-19: Analysis of 2 Cohorts From Different Periods of the Pandemic.Shirkhan Amikishiyev, M Guven Gunver, Murat Bektas
|Jul 22, 2021
Reinfection with SARS-CoV-2 in a kidney transplant recipient.Shirkhan Amikishiyev, Erol Demir, Sarvan Aghamuradov
Pageof 1
Frequent Collaborators
3 joint publications
Ahmet Gul
2 joint publications
Sarvan Aghamuradov
1 joint publications
Erol Demir
1 joint publications
Nurana Garayeva
1 joint publications
Ayse Serra Artan
1 joint publications
Aydin Turkmen
1 joint publications
Rabia Deniz
1 joint publications
Yasemin Yalçinkaya
1 joint publications
Bahar Artim Esen
1 joint publications
Numuna Aliyeva
